APA (7th ed.) Citation

F, V., D, P., F, P., J, B., V, Z., A, G., . . . AL, D. S. (2025). Resistance of recurrent epidermal growth factor receptor-altered glioblastoma to anti-epidermal growth factor receptor targeted therapy with osimertinib. The oncologist, 30(7), . https://doi.org/10.1093/oncolo/oyaf146

Chicago Style (17th ed.) Citation

F, Villanacci, et al. "Resistance of Recurrent Epidermal Growth Factor Receptor-altered Glioblastoma to Anti-epidermal Growth Factor Receptor Targeted Therapy with Osimertinib." The Oncologist 30, no. 7 (2025). https://doi.org/10.1093/oncolo/oyaf146.

MLA (9th ed.) Citation

F, Villanacci, et al. "Resistance of Recurrent Epidermal Growth Factor Receptor-altered Glioblastoma to Anti-epidermal Growth Factor Receptor Targeted Therapy with Osimertinib." The Oncologist, vol. 30, no. 7, 2025, https://doi.org/10.1093/oncolo/oyaf146.